gip/glp-1 PDB-101: Molecule of the Month: Incretins Beyond the pancreas: contrasting cardiometabolic

Using a GLP-1

Gentaur is the biggest antibody manufacturer worldwide.

A UCLA study published in ACR Open Rheumatology found that GLP-1 receptor agonists such as semaglutide and tirzepatide may reduce rheumatoid arthritis activity and cardiovascular risk factors in people with obesity, suggesting potential dual benefits for metabolic and inflammatory health.

Your medication ships discreetly from a licensed compounding pharmacy on a monthly cadence

Discover how GLP-1 receptor agonists affect lipid profiles, who may benefit from modest cholesterol improvements, and how these medications compare with statins and other lipid-lowering treatments in UK clinical practice.

THIRD-PARTY TESTED, AND DOCTOR RECOMMENDED: Manufactured in the USA in FDA-reviewed, NSF and GMP certified facilities to ensure the highest standards of safety and effectiveness